Entrada Therapeutics (TRDA) FCF Margin (2023 - 2026)

Entrada Therapeutics' quarterly FCF Margin came in at 4765.14% in Q1 2026, down 457227.0% year-on-year from N/an in Q1 2025, and down 86.2% quarter-over-quarter from 2559.2% in Q4 2025.

Entrada Therapeutics has reported FCF Margin for 4 years, with the latest figure at 4765.14% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 457227.0% year-over-year to 4765.14%; the trailing twelve-month figure through Mar 2026 stood at 2293.43% (down 226126.0% YoY), and the FY2025 full-year result was 509.63%, down 48965.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 4765.14%, down from 2559.2% in the prior quarter.
  • The five-year high for FCF Margin was 798.62% in Q1 2023, with the low at 4765.14% in Q1 2026.
  • Average FCF Margin over 4 years is 799.29%, with a median of 114.68% recorded in 2024.
  • Year-over-year, FCF Margin jumped 24246 bps in 2024 and plunged 457227 bps in 2026.
  • Tracing TRDA's FCF Margin over 4 years: stood at 9.37% in 2023, then slumped by 816 bps to 85.85% in 2024, then sank by 2881 bps to 2559.2% in 2025, then slumped by 86 bps to 4765.14% in 2026.
  • The last three FCF Margin figures came in at 4765.14% (Q1 2026), 2559.2% (Q4 2025), and 1754.21% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -3.98%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 43.35%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 23.53%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 4.17%
10 Entrada Therapeutics 295.78 Mn 295.78 Mn - -4,765.14%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -4,765.14%
Dec 31, 2025 -2,559.20%
Sep 30, 2025 -1,754.21%
Jun 30, 2025 -1,453.59%
Mar 31, 2025 -192.87%
Dec 31, 2024 -85.85%
Sep 30, 2024 -114.68%
Jun 30, 2024 40.96%
Mar 31, 2024 -44.58%
Dec 31, 2023 -9.37%
Sep 30, 2023 -49.39%
Jun 30, 2023 -201.50%
Mar 31, 2023 798.62%